CymaBay Therapeutics, Inc. Nonoperating Income (Expense) in USD from 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CymaBay Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to Q4 2023.
  • CymaBay Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $596K.
  • CymaBay Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was -$3.69M, a 71.4% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$3.69M, a 71.4% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$12.9M, a 434% decline from 2021.
  • CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.42M, a 250% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

CymaBay Therapeutics, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$3.69M $596K +$3.75M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$7.44M -$1.68M +$1.47M +46.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$8.91M -$709K +$2.62M +78.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$11.5M -$1.9M +$1.36M +41.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$12.9M -$3.16M -$1.12M -55.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$11.8M -$3.14M -$2.65M -537% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$9.12M -$3.33M -$3.37M -7657% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$5.75M -$3.27M -$3.33M -4976% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2.42M -$2.03M -$2.16M -1767% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$260K -$493K -$722K -315% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $462K $44K -$382K -89.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $844K $67K -$772K -92% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.62M $122K -$1.01M -89.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $2.63M $229K -$1.2M -83.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.82M $426K -$1.18M -73.5% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $5.01M $839K -$337K -28.7% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $5.34M $1.13M +$25K +2.26% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $5.32M $1.43M -$1.14M -44.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.46M $1.61M +$1.17M +266% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $5.29M $1.18M +$5.33M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$43K $1.11M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $2.57M +$4.41M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $440K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$4.16M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 -$1.84M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06

CymaBay Therapeutics, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.69M +$9.2M +71.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$12.9M -$10.5M -434% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$2.42M -$4.03M -250% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $1.62M -$3.73M -69.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $5.34M +$5.39M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$43K +$6.19M +99.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$6.23M -$5.15M -474% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 -$1.09M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.